XML 30 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Organization and Summary of Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Revenues
A summary of revenues by service type as a percentage of total revenues follows:
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Patient service revenues:
   Surgical facilities revenues95.8 %95.6 %95.9 %95.7 %
   Ancillary services revenues2.4 %2.7 %2.5 %2.8 %
Total patient service revenues98.2 %98.3 %98.4 %98.5 %
Other service revenues1.8 %1.7 %1.6 %1.5 %
Total revenues100.0 %100.0 %100.0 %100.0 %
The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):
Three Months Ended September 30,
20232022
Amount%Amount%
Patient service revenues:
Private insurance$347.1 52.4 %$301.9 49.5 %
Government271.6 41.0 %269.5 44.2 %
Self-pay16.9 2.6 %16.0 2.6 %
Other (1)
26.7 4.0 %22.7 3.7 %
Total patient service revenues662.3 100.0 %610.1 100.0 %
Other service revenues11.8 10.5 
Total revenues$674.1 $620.6 
Nine Months Ended September 30,
20232022
Amount%Amount%
Patient service revenues:
Private insurance$1,024.3 51.8 %$910.5 50.4 %
Government837.6 42.4 %776.5 43.0 %
Self-pay49.6 2.5 %49.2 2.7 %
Other (1)
65.2 3.3 %68.9 3.9 %
Total patient service revenues1,976.7 100.0 %1,805.1 100.0 %
Other service revenues31.2 27.1 
Total revenues$2,007.9 $1,832.2 
(1)Other is comprised of anesthesia service agreements, automobile liability, letters of protection and other payor types.
Schedule of Rollforward of Goodwill
A summary of activity related to goodwill for the nine months ended September 30, 2023 is as follows (in millions):
Balance at December 31, 2022$4,137.1 
Acquisitions, including post acquisition adjustments145.0 
Disposals(37.0)
Balance at September 30, 2023$4,245.1 
Schedule of Rollforward of Noncontrolling Interest - Redeemable
A summary of activity related to non-controlling interests—redeemable is as follows (in millions):
Nine Months Ended September 30,
20232022
Balance at beginning of period$342.0 $330.2 
Net income attributable to non-controlling interests—redeemable25.6 29.9 
(Disposal) acquisition of shares of non-controlling interests, net—redeemable(2.2)11.9 
Distributions to non-controlling interest—redeemable holders(33.2)(33.2)
Balance at end of period$332.2 $338.8 
Schedule of Carrying Amounts and Fair Values of Long-Term Debt
A summary of the carrying amounts and estimated fair values of the Company's long-term debt follows (in millions):
Carrying AmountFair Value
September 30,
2023
December 31,
2022
September 30,
2023
December 31,
2022
Senior secured term loan$1,370.4 $1,370.0 $1,370.4 $1,359.7 
6.750% senior unsecured notes due 2025
$185.0 $185.0 $183.2 $183.4 
10.000% senior unsecured notes due 2027
$320.0 $320.0 $323.6 $326.8